Celine Devroye - Publications

Istituto Italiano di Tecnologia, Genoa 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Cathala A, Devroye C, Robert É, Vallée M, Revest JM, Artigas F, Spampinato U. Serotonin2B receptor blockade in the rat dorsal raphe nucleus suppresses cocaine-induced hyperlocomotion through an opposite control of mesocortical and mesoaccumbens dopamine pathways. Neuropharmacology. 180: 108309. PMID 32956675 DOI: 10.1016/j.neuropharm.2020.108309  0.6
2019 Castellani G, Contarini G, Mereu M, Albanesi E, Devroye C, D'Amore C, Ferretti V, De Martin S, Papaleo F. Dopamine-Mediated Immunomodulation affects Choroid Plexus Function. Brain, Behavior, and Immunity. PMID 31175999 DOI: 10.1016/j.bbi.2019.06.006  0.36
2018 Cathala A, Devroye C, Drutel G, Revest JM, Artigas F, Spampinato U. Serotonin receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons. Experimental Neurology. 311: 57-66. PMID 30257183 DOI: 10.1016/j.expneurol.2018.09.015  0.6
2017 Devroye C, Cathala A, Piazza PV, Spampinato U. The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research. Pharmacology & Therapeutics. PMID 28757154 DOI: 10.1016/j.pharmthera.2017.07.014  0.6
2017 Devroye C, Haddjeri N, Cathala A, Rovera R, Drago F, Piazza PV, Artigas F, Spampinato U. Opposite controls of mesocortical and mesoaccumbal dopamine pathways by serotonin2B receptor blockade: Involvement of medial prefrontal cortex serotonin1A receptors. Neuropharmacology. PMID 28390892 DOI: 10.1016/j.neuropharm.2017.04.001  0.6
2016 Devroye C, Cathala A, Haddjeri N, Rovera R, Vallée M, Drago F, Piazza PV, Spampinato U. Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: New opportunities for the treatment of schizophrenia. Neuropharmacology. 109: 59-68. PMID 27260325 DOI: 10.1016/j.neuropharm.2016.05.024  0.6
2015 Devroye C, Cathala A, Di Marco B, Caraci F, Drago F, Piazza PV, Spampinato U. Central serotonin2B receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow. Neuropharmacology. 97: 329-37. PMID 26116760 DOI: 10.1016/j.neuropharm.2015.06.012  0.6
2015 Devroye C, Cathala A, Maitre M, Piazza PV, Abrous DN, Revest JM, Spampinato U. Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow. Neuropharmacology. 89: 375-81. PMID 25446572 DOI: 10.1016/j.neuropharm.2014.10.016  0.6
2015 Cathala A, Devroye C, Maitre M, Piazza PV, Abrous DN, Revest JM, Spampinato U. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine. Addiction Biology. 20: 445-57. PMID 24661380 DOI: 10.1111/adb.12137  0.6
2013 Devroye C, Filip M, Przegaliński E, McCreary AC, Spampinato U. Serotonin2C receptors and drug addiction: focus on cocaine. Experimental Brain Research. 230: 537-45. PMID 23748692 DOI: 10.1007/s00221-013-3593-2  0.6
Show low-probability matches.